FDA Rolls Out Guides for Multiple Generic Drug Tests
Published Date: 5/21/2025
Notice
Summary
The FDA just released new and updated guides to help drug makers design studies proving their generic drugs work like the originals. These guides affect companies making generic medicines and aim to speed up approval while saving time and money. Check them out soon to stay ahead and keep your products on track!
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
Draft BE Guidances for ANDAs
The FDA announced the availability of additional draft and revised draft product-specific guidances that give product-specific recommendations on the design of bioequivalence (BE) studies. These recommendations are intended to support abbreviated new drug applications (ANDAs).
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in